Effect of dietary lipids on paraoxonase-1 activity and gene expression

被引:36
|
作者
Ferretti, G. [1 ]
Bacchetti, T. [2 ]
机构
[1] Univ Politecn Marche, Dipartimento Sci Clin Sperimentali & Odontostomat, I-60131 Ancona, Italy
[2] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, I-60131 Ancona, Italy
关键词
Dietary lipids; Fatty acids; High density lipoproteins (HDL); Nutrigenomics; Paraoxonase-1 (PON1); MACROPHAGE CHOLESTEROL EFFLUX; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; HIGH-FAT DIET; OXIDATIVE STRESS; HEALTHY-SUBJECTS; SATURATED FAT; HDL BINDING; OLEIC-ACID; OLIVE OIL;
D O I
10.1016/j.numecd.2011.08.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Aim of the paper was to summarize the literature about the effect of dietary lipids on activity of paraoxonase-1 (PON1), a multifunctional enzyme associated with high density lipoprotein (HDL). PON1 exerts a protective effect against oxidative damage of cells and lipoproteins and modulates the susceptibility of HDL and LDL to atherogenic modifications such as homocysteinylation. Data synthesis: The present review shows evidence that the amount and the composition of dietary lipids are key factors in the modulation of PON1. The effect of dietary lipids is also modulated by PON1 polymorphisms. The molecular mechanisms involved include an effect on PON1 hepatic synthesis or secretion and/or modification of PON1 interactions with HDL. Changes of PON1 activity could also be related to dietary intake of oxidized lipids that behave as PON1 inhibitors. Conclusion: Dietary fatty acids by the modulation of PON1 gene expression and activity could constitute an useful approach for the prevention of human diseases associated with oxidative damage. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 50 条
  • [31] Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress
    Cüneyt Türkeş
    Hakan Söyüt
    Şükrü Beydemir
    Pharmacological Reports, 2014, 66 : 74 - 80
  • [32] Targeting paraoxonase-1 in atherosclerosis
    Mackness, Mike
    Mackness, Bharti
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 829 - 837
  • [33] Paraoxonase-1 and cardiovascular disease
    Mackness, B.
    Mackness, M. L.
    PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM, 2008, 6 : 51 - 60
  • [34] Solubilization and Humanization of Paraoxonase-1
    Sarkar, Mohosin
    Harsch, Christina Keventzidis
    Matic, George T.
    Hoffman, Kathryn
    Norris, Joseph R., III
    Otto, Tamara C.
    Lenz, David E.
    Cerasoli, Douglas M.
    Magliery, Thomas J.
    JOURNAL OF LIPIDS, 2012, 2012
  • [36] Dietary lipids and gene expression
    Roche, HM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 999 - 1002
  • [37] Effect of Nutritional Status on Human Paraoxonase-1 Activity in Patients with Chronic Kidney Disease
    Sztanek, Ferenc
    Seres, Ildiko
    Harangi, Mariann
    Locsey, Lajos
    Koncsos, Peter
    Paragh, Gyoergy
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01): : 310 - 319
  • [38] Association analysis of the paraoxonase-1 gene with Alzheimer's disease
    Cellini, Elena
    Tedde, Andrea
    Bagnoli, Silvia
    Nacmias, Benedetta
    Piacentini, Silvia
    Bessi, Valentina
    Bracco, Laura
    Sorbi, Sandro
    NEUROSCIENCE LETTERS, 2006, 408 (03) : 199 - 202
  • [39] Evidence for association between paraoxonase-1 activity and diseases Reply
    Karsen, Hasan
    AFRICAN HEALTH SCIENCES, 2013, 13 (01) : 175 - 175
  • [40] Misunderstandings about paraoxonase-1
    Mackness, Michael
    Sozmen, Eser Y.
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (01)